Author
Listed:
- Julia Kargl
(Clinical Research Division
Institute of Experimental and Clinical Pharmacology, Medical University of Graz)
- Stephanie E. Busch
(Clinical Research Division)
- Grace H. Y. Yang
(Clinical Research Division)
- Kyoung-Hee Kim
(Clinical Research Division)
- Mark L. Hanke
(Clinical Research Division)
- Heather E. Metz
(Clinical Research Division)
- Jesse J. Hubbard
(Clinical Research Division)
- Sylvia M. Lee
(Clinical Research Division)
- David K. Madtes
(Clinical Research Division
University of Washington)
- Martin W. McIntosh
(Fred Hutchinson Cancer Research Center)
- A. McGarry Houghton
(Clinical Research Division
University of Washington
Human Biology Division)
Abstract
The response rate to immune checkpoint inhibitor therapy for non-small-cell lung cancer (NSCLC) is just 20%. To improve this figure, several early phase clinical trials combining novel immunotherapeutics with immune checkpoint blockade have been initiated. Unfortunately, these trials have been designed without a strong foundational knowledge of the immune landscape present in NSCLC. Here, we use a flow cytometry panel capable of measuring 51 immune cell populations to comprehensively identify the immune cell composition and function in NSCLC. The results show that the immune cell composition is fundamentally different in lung adenocarcinoma as compared with lung squamous cell carcinoma, and that neutrophils are the most prevalent immune cell type. Using T-cell receptor-β sequencing and tumour reactivity assays, we predict that tumour reactive T cells are frequently present in NSCLC. These results should help to guide the design of clinical trials and the direction of future research in this area.
Suggested Citation
Julia Kargl & Stephanie E. Busch & Grace H. Y. Yang & Kyoung-Hee Kim & Mark L. Hanke & Heather E. Metz & Jesse J. Hubbard & Sylvia M. Lee & David K. Madtes & Martin W. McIntosh & A. McGarry Houghton, 2017.
"Neutrophils dominate the immune cell composition in non-small cell lung cancer,"
Nature Communications, Nature, vol. 8(1), pages 1-11, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14381
DOI: 10.1038/ncomms14381
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14381. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.